Summary: H.R.5811 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.5811. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (05/15/2018)

Long-Term Opioid Efficacy Act of 2018

This bill expands the authority of the Food and Drug Administration (FDA) to require post-approval studies or clinical trials with respect to controlled substances (e.g., opioids).